RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/14565662http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/14565662http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/14565662http://www.w3.org/2000/01/rdf-schema#comment"We report the characterization of a new gene (E4.5) that maps at chromosome band 13q14.3, a chromosomal area frequently deleted in chronic lymphocytic leukemia (CLL) and in other lymphoid malignancies. E4.5 gene encodes for a 4 kb mRNA expressed in various tissues and has an open reading frame of 531 amino acids. The predicted E4.5 protein shows strong homology with the human regulator of chromosome condensation (RCC1) protein, the principal GTP exchange factor for Ran protein. The E4.5 protein contains a BTB domain in its N-terminus, a protein-protein interaction motif. Therefore, we propose that E4.5 is a new member of the RCC1-related guanine nucleotide exchange factor (GEF) family with potent interaction with other proteins and unknown function. Until now, no tumor suppressor genes have been mapped in the 13q14.3 minimal deleted region (MDR) in patients with CLL. It has been proposed that loss of the 13q14.3 MDR may contribute to lymphoid neoplasia by altering the expression/function of genes located on 13q14.3 outside the MDR. The E4.5 is one of these genes with a potential role in the pathogenesis of CLL."xsd:string
http://purl.uniprot.org/citations/14565662http://purl.org/dc/terms/identifier"doi:10.3109/10428190309178782"xsd:string
http://purl.uniprot.org/citations/14565662http://purl.org/dc/terms/identifier"doi:10.3109/10428190309178782"xsd:string
http://purl.uniprot.org/citations/14565662http://purl.uniprot.org/core/author"Papaioannou M."xsd:string
http://purl.uniprot.org/citations/14565662http://purl.uniprot.org/core/author"Papaioannou M."xsd:string
http://purl.uniprot.org/citations/14565662http://purl.uniprot.org/core/author"Hoffbrand A.V."xsd:string
http://purl.uniprot.org/citations/14565662http://purl.uniprot.org/core/author"Hoffbrand A.V."xsd:string
http://purl.uniprot.org/citations/14565662http://purl.uniprot.org/core/author"Panayiotidis P."xsd:string
http://purl.uniprot.org/citations/14565662http://purl.uniprot.org/core/author"Panayiotidis P."xsd:string
http://purl.uniprot.org/citations/14565662http://purl.uniprot.org/core/author"Karali V."xsd:string
http://purl.uniprot.org/citations/14565662http://purl.uniprot.org/core/author"Karali V."xsd:string
http://purl.uniprot.org/citations/14565662http://purl.uniprot.org/core/author"Kotsi P."xsd:string
http://purl.uniprot.org/citations/14565662http://purl.uniprot.org/core/author"Kotsi P."xsd:string
http://purl.uniprot.org/citations/14565662http://purl.uniprot.org/core/author"Sfikakis P.P."xsd:string
http://purl.uniprot.org/citations/14565662http://purl.uniprot.org/core/author"Sfikakis P.P."xsd:string
http://purl.uniprot.org/citations/14565662http://purl.uniprot.org/core/author"Solomou E.E."xsd:string
http://purl.uniprot.org/citations/14565662http://purl.uniprot.org/core/author"Solomou E.E."xsd:string
http://purl.uniprot.org/citations/14565662http://purl.uniprot.org/core/author"Vervessou E."xsd:string
http://purl.uniprot.org/citations/14565662http://purl.uniprot.org/core/author"Vervessou E."xsd:string
http://purl.uniprot.org/citations/14565662http://purl.uniprot.org/core/date"2003"xsd:gYear
http://purl.uniprot.org/citations/14565662http://purl.uniprot.org/core/date"2003"xsd:gYear
http://purl.uniprot.org/citations/14565662http://purl.uniprot.org/core/name"Leuk. Lymphoma"xsd:string
http://purl.uniprot.org/citations/14565662http://purl.uniprot.org/core/name"Leuk. Lymphoma"xsd:string